These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15959656)

  • 1. Turning darkness into light. A new landmark study on the treatment of adolescent depression. Comments on the TADS study.
    Apter A; Kronenberg S; Brent D
    Eur Child Adolesc Psychiatry; 2005 May; 14(3):113-6. PubMed ID: 15959656
    [No Abstract]   [Full Text] [Related]  

  • 2. Glad for what TADS adds, but many TADS grads still sad.
    Brent DA
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1461-4. PubMed ID: 17135991
    [No Abstract]   [Full Text] [Related]  

  • 3. After TADS, can we measure up, catch up, and ante up?
    Jensen PS
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1456-60. PubMed ID: 17135990
    [No Abstract]   [Full Text] [Related]  

  • 4. Cost-effectiveness of depression treatment for adolescents.
    Norquist G; McGuire TG; Essock SM
    Am J Psychiatry; 2008 May; 165(5):549-52. PubMed ID: 18450932
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological management of treatment-resistant pediatric depression.
    Kratochvil CJ; Wagner KD; Emslie G; March J
    J Am Acad Child Adolesc Psychiatry; 2005 Feb; 44(2):198-200. PubMed ID: 15689734
    [No Abstract]   [Full Text] [Related]  

  • 6. Trajectories of Symptom Change in the Treatment for Adolescents With Depression Study.
    Scott K; Lewis CC; Marti CN
    J Am Acad Child Adolesc Psychiatry; 2019 Mar; 58(3):319-328. PubMed ID: 30768414
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A depressed adolescent at high risk of suicidal behavior.
    Vitiello B; Pearson JL
    Am J Psychiatry; 2008 Mar; 165(3):323-8; quiz 408. PubMed ID: 18316430
    [No Abstract]   [Full Text] [Related]  

  • 8. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks.
    March J; Silva S; Vitiello B;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1393-403. PubMed ID: 17135984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS).
    Curry J; Rohde P; Simons A; Silva S; Vitiello B; Kratochvil C; Reinecke M; Feeny N; Wells K; Pathak S; Weller E; Rosenberg D; Kennard B; Robins M; Ginsburg G; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1427-39. PubMed ID: 17135988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functioning and quality of life in the Treatment for Adolescents with Depression Study (TADS).
    Vitiello B; Rohde P; Silva S; Wells K; Casat C; Waslick B; Simons A; Reinecke M; Weller E; Kratochvil C; Walkup J; Pathak S; Robins M; March J;
    J Am Acad Child Adolesc Psychiatry; 2006 Dec; 45(12):1419-26. PubMed ID: 17135987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised controlled trial of cognitive behaviour therapy in adolescents with major depression treated by selective serotonin reuptake inhibitors. The ADAPT trial.
    Goodyer IM; Dubicka B; Wilkinson P; Kelvin R; Roberts C; Byford S; Breen S; Ford C; Barrett B; Leech A; Rothwell J; White L; Harrington R
    Health Technol Assess; 2008 May; 12(14):iii-iv, ix-60. PubMed ID: 18462573
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research knowledge among the participants in the Treatment for Adolescents With Depression Study (TADS).
    Vitiello B; Kratochvil CJ; Silva S; Curry J; Reinecke M; Pathak S; Waslick B; Hughes CW; Prentice ED; May DE; March JS
    J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1642-50. PubMed ID: 18030086
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial.
    Davey CG; Chanen AM; Hetrick SE; Cotton SM; Ratheesh A; Amminger GP; Koutsogiannis J; Phelan M; Mullen E; Harrison BJ; Rice S; Parker AG; Dean OM; Weller A; Kerr M; Quinn AL; Catania L; Kazantzis N; McGorry PD; Berk M
    Lancet Psychiatry; 2019 Sep; 6(9):735-744. PubMed ID: 31371212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment response in depressed adolescents with and without co-morbid attention-deficit/hyperactivity disorder in the Treatment for Adolescents with Depression Study.
    Kratochvil CJ; May DE; Silva SG; Madaan V; Puumala SE; Curry JF; Walkup J; Kepley H; Vitiello B; March JS
    J Child Adolesc Psychopharmacol; 2009 Oct; 19(5):519-27. PubMed ID: 19877976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to tryptophan depletion in major depression treated with either cognitive therapy or selective serotonin reuptake inhibitor antidepressants.
    O'Reardon JP; Chopra MP; Bergan A; Gallop R; DeRubeis RJ; Crits-Christoph P
    Biol Psychiatry; 2004 May; 55(9):957-9. PubMed ID: 15110741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of adolescent depression: what we have come to know.
    Vitiello B
    Depress Anxiety; 2009; 26(5):393-5. PubMed ID: 19404989
    [No Abstract]   [Full Text] [Related]  

  • 17. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes.
    March JS; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J
    Arch Gen Psychiatry; 2007 Oct; 64(10):1132-43. PubMed ID: 17909125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical messages from the Treatment for Adolescents With Depression Study (TADS).
    March JS; Vitiello B
    Am J Psychiatry; 2009 Oct; 166(10):1118-23. PubMed ID: 19723786
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extreme response style in recurrent and chronically depressed patients: change with antidepressant administration and stability during continuation treatment.
    Peterson TJ; Feldman G; Harley R; Fresco DM; Graves L; Holmes A; Bogdan R; Papakostas GI; Bohn L; Lury RA; Fava M; Segal ZV
    J Consult Clin Psychol; 2007 Feb; 75(1):145-53. PubMed ID: 17295573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial.
    March J; Silva S; Petrycki S; Curry J; Wells K; Fairbank J; Burns B; Domino M; McNulty S; Vitiello B; Severe J;
    JAMA; 2004 Aug; 292(7):807-20. PubMed ID: 15315995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.